Diffusion Weighted Magnetic Resonance Imaging of the Breast During Chemotherapy: Response Evaluation

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01684735

Enrollment

Registered

2012-09-13

Start date

2012-03-31

Completion date

2014-12-31

Last updated

2023-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

diffusion-weighted magnetic resonance imaging

Brief summary

Evaluation of the response to chemotherapy in breast cancer patients by the use of Diffusion-weighted magnetic resonance imaging of the breast before the start of chemotherapy, after one and 3 cycles of therapy and at the end of the therapy.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* core biopsy with diagnosis of breast cancer * start of neo-adjuvant chemotherapy

Exclusion criteria

* magnetic resonance imaging incompatibility

Design outcomes

Primary

Measure	Time frame	Description
Response to chemotherapy	1 year	outcome is the results of pathology after chemotherapy and surgery. Data will be collected for a period of 1 year.

Countries

Belgium

Outcome results